Le Lézard
Classified in: Health
Subjects: NPT, CPG, CMG

Historic change opens the door for more blood and plasma donors: human variant of 'mad cow' eligibility rule gone for good


Two-decade long eligibility requirement lifted for people who spent time in the United Kingdom, Republic of Ireland or France; newly eligible donors welcome starting December 4

OTTAWA, ON, Nov. 23, 2023 /CNW/ - Canadian Blood Services is pleased to announce it has received Health Canada approval on a long-awaited eligibility change that could potentially welcome thousands of new blood and plasma donors.

For more than two decades, people who lived or spent time in the United Kingdom, Republic of Ireland or France in the 1980s and 1990s, were ineligible to donate. This eligibility criteria was put into place in the late 1990s by blood operators around the world as a precautionary measure during the 'mad cow' outbreak. Now, with nearly 30 years of surveillance and research from Canada and internationally, this criteria is no longer required.   

"Our data tells us that since 2003 approximately 70,000 people in Canada tried to donate, but were not able to because of this criteria," says Ron Vezina, vice president, public affairs. "Twenty years later, we hope those who are still able to do so, will come back to visit our donor centres after December 4. Now your time there, means you can make all the difference here."

Decades of research made this change possible

When the 'mad cow' outbreak occurred, little was known about the human form, variant Creutzfeldt-Jakob disease (vCJD), and the possibility of it being transmitted through blood. Three decades of surveillance and research has now demonstrated that removing criteria related to potential exposure to beef products and transfusions in specific countries will not lead to an increase in vCJD.

"We continuously review available research, advances in blood testing and manufacturing and guidance from blood operators around the world to assess and update donor screening criteria and help ensure continual improvement in blood safety and availability," said Dr. Aditi Khandelwal, medical officer, Canadian Blood Services. "Learnings from nearly 30 years of vCJD surveillance and improved understanding of this illness as well as a comprehensive risk modelling exercise specific to Canada has found that the criteria can now be removed."

In February 2022, Canadian Blood Services removed this criteria to permit people who lived or spent time in Saudi Arabia, Germany, Italy, Netherlands (Holland), Switzerland, Austria, Belgium, Spain, Portugal, Denmark, Luxembourg, and Liechtenstein to donate blood and plasma.

Now with the approval to remove the criteria for the United Kingdom, Republic of Ireland and France, Canadian Blood Services is aligned with other blood operators that no longer have this rule in place, including the United States (2022), Australia (2022) and Israel (2023).

Appointments available for newly eligible donors on or after December 4

People who are interested in donating are encouraged to visit our website or call 1-888-2DONATE (236-6283) to get more information or to book an appointment on or after December 4, if they were previously ineligible due to:

"We know there are many people eager to start donating and we're calling on you now to come in and donate," says Vezina. "The need for blood and plasma never stops, so when you're ready to do so, we look forward to welcoming you at one of our donor centres or mobile events any time after December 4."

Canadian Blood Services needs 100,000 new donors every year to keep Canada's Lifeline strong. Donors are particularly needed during the winter holiday season. Between December 4, 2023 to January 7, 2024, there are thousands of appointments to fill across Canada.

Don't count yourself out. Canadian Blood Services regularly updates eligibility criteria for donating blood and plasma. You may be able to donate?even if you couldn't before. More information on eligibility criteria can be found on our website.

If you cannot donate, you can still help save lives in other ways. Visit blood.ca to learn how you can make all the difference for patients and their families. You can also ask friends, family and colleagues to donate blood or plasma and share the message on social media.

About Canadian Blood Services? 

Canadian Blood Services is a not-for-profit charitable organization. Regulated by Health Canada as a biologics manufacturer and primarily funded by the provincial and territorial ministries of health, Canadian Blood Services operates with a national scope, infrastructure and governance that make it unique within Canadian healthcare. In the domain of blood, plasma and stem cells, we provide services for patients on behalf of all provincial and territorial governments except Quebec. The national transplant registry for interprovincial organ sharing and related programs reaches into all provinces and territories. Together, we are Canada's Lifeline.

[email protected]
1-877-709-7773

SOURCE Canadian Blood Services


These press releases may also interest you

at 09:05
Smart Meter, the leading supplier of Cellular Remote Patient Monitoring (RPM)tm solutions, has introduced a new version of the iGlucose, its patented cellular-connected glucose meter used by over 200,000 people with diabetes since 2019. The...

at 09:00
Today, the Honourable Gary Anandasangaree, Minister of Crown-Indigenous Relations; the Honourable Patty Hajdu, Minister of Indigenous Services and Minister responsible for FedNor; the Honourable Dan Vandal, Minister of Northern Affairs; and the...

at 08:05
GE HealthCare today unveiled SIGNA MAGNUS, an FDA 510(k) pending head-only magnetic resonance (MR) scanner designed to explore advancements in neuroscience, which have been restricted by the performance limitations of conventional whole-body MR...

at 07:00
To mark National Hospice Palliative Care Week, the Quebec Coalition for Palliative Care Access (the Coalition) is proud to celebrate the positive impact of palliative care on the well-being of people with life-limiting illness. Palliative care is...

at 06:00
A native born and trained Brazilian oncologist is in the forefront of a new era in the treatment of cancer patients with cutting edge proton therapy medical technology developed in Israel by P-Cure. "It is my dream to be able to bring the P-Cure...

4 mai 2024
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced results from a new analysis of the ATLAS trial, which estimates using Kaplan Meier...



News published on and distributed by: